世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pediatric HIV Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5935
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、小児HIV感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（無症状、軽症、中症、重症）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・小児HIV感染症治療の市場動向
・企業の競争状況、市場シェア
・小児HIV感染症治療の種類別市場規模と予測2016-2027（無症状、軽症、中症、重症）
・小児HIV感染症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）
・小児HIV感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・小児HIV感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・小児HIV感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・小児HIV感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・小児HIV感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GSK、F.Hoffmann-La Roche、Johnson & Johnson Services、ViiV Healthcare、Apotex、Camber Pharmaceuticals）
・結論

Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF

Market Analysis and Insights: Global Pediatric HIV Infection Treatment Market
The global Pediatric HIV Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric HIV Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric HIV Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric HIV Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric HIV Infection Treatment market.

Global Pediatric HIV Infection Treatment Scope and Market Size
Pediatric HIV Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric HIV Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Not Symptomatic
Mildly Symptomatic
Moderately Symptomatic
Severely Symptomatic

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drugstore
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
F.Hoffmann-La Roche
Johnson & Johnson Services
ViiV Healthcare
Apotex
Camber Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric HIV Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Not Symptomatic
1.2.3 Mildly Symptomatic
1.2.4 Moderately Symptomatic
1.2.5 Severely Symptomatic
1.3 Market by Application
1.3.1 Global Pediatric HIV Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drugstore
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediatric HIV Infection Treatment Market Perspective (2016-2027)
2.2 Pediatric HIV Infection Treatment Growth Trends by Regions
2.2.1 Pediatric HIV Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediatric HIV Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pediatric HIV Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pediatric HIV Infection Treatment Industry Dynamic
2.3.1 Pediatric HIV Infection Treatment Market Trends
2.3.2 Pediatric HIV Infection Treatment Market Drivers
2.3.3 Pediatric HIV Infection Treatment Market Challenges
2.3.4 Pediatric HIV Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediatric HIV Infection Treatment Players by Revenue
3.1.1 Global Top Pediatric HIV Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Pediatric HIV Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pediatric HIV Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediatric HIV Infection Treatment Revenue
3.4 Global Pediatric HIV Infection Treatment Market Concentration Ratio
3.4.1 Global Pediatric HIV Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric HIV Infection Treatment Revenue in 2020
3.5 Pediatric HIV Infection Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric HIV Infection Treatment Product Solution and Service
3.7 Date of Enter into Pediatric HIV Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric HIV Infection Treatment Breakdown Data by Type
4.1 Global Pediatric HIV Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pediatric HIV Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Pediatric HIV Infection Treatment Breakdown Data by Application
5.1 Global Pediatric HIV Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pediatric HIV Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediatric HIV Infection Treatment Market Size (2016-2027)
6.2 North America Pediatric HIV Infection Treatment Market Size by Type
6.2.1 North America Pediatric HIV Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Pediatric HIV Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Pediatric HIV Infection Treatment Market Size by Type (2016-2027)
6.3 North America Pediatric HIV Infection Treatment Market Size by Application
6.3.1 North America Pediatric HIV Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Pediatric HIV Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Pediatric HIV Infection Treatment Market Size by Application (2016-2027)
6.4 North America Pediatric HIV Infection Treatment Market Size by Country
6.4.1 North America Pediatric HIV Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Pediatric HIV Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pediatric HIV Infection Treatment Market Size (2016-2027)
7.2 Europe Pediatric HIV Infection Treatment Market Size by Type
7.2.1 Europe Pediatric HIV Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pediatric HIV Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pediatric HIV Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Pediatric HIV Infection Treatment Market Size by Application
7.3.1 Europe Pediatric HIV Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pediatric HIV Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pediatric HIV Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Pediatric HIV Infection Treatment Market Size by Country
7.4.1 Europe Pediatric HIV Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pediatric HIV Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediatric HIV Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediatric HIV Infection Treatment Market Size (2016-2027)
9.2 Latin America Pediatric HIV Infection Treatment Market Size by Type
9.2.1 Latin America Pediatric HIV Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pediatric HIV Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pediatric HIV Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Pediatric HIV Infection Treatment Market Size by Application
9.3.1 Latin America Pediatric HIV Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pediatric HIV Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pediatric HIV Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Pediatric HIV Infection Treatment Market Size by Country
9.4.1 Latin America Pediatric HIV Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pediatric HIV Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediatric HIV Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Pediatric HIV Infection Treatment Introduction
11.1.4 GSK Revenue in Pediatric HIV Infection Treatment Business (2016-2021)
11.1.5 GSK Recent Development
11.2 F.Hoffmann-La Roche
11.2.1 F.Hoffmann-La Roche Company Details
11.2.2 F.Hoffmann-La Roche Business Overview
11.2.3 F.Hoffmann-La Roche Pediatric HIV Infection Treatment Introduction
11.2.4 F.Hoffmann-La Roche Revenue in Pediatric HIV Infection Treatment Business (2016-2021)
11.2.5 F.Hoffmann-La Roche Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Johnson & Johnson Services Business Overview
11.3.3 Johnson & Johnson Services Pediatric HIV Infection Treatment Introduction
11.3.4 Johnson & Johnson Services Revenue in Pediatric HIV Infection Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Services Recent Development
11.4 ViiV Healthcare
11.4.1 ViiV Healthcare Company Details
11.4.2 ViiV Healthcare Business Overview
11.4.3 ViiV Healthcare Pediatric HIV Infection Treatment Introduction
11.4.4 ViiV Healthcare Revenue in Pediatric HIV Infection Treatment Business (2016-2021)
11.4.5 ViiV Healthcare Recent Development
11.5 Apotex
11.5.1 Apotex Company Details
11.5.2 Apotex Business Overview
11.5.3 Apotex Pediatric HIV Infection Treatment Introduction
11.5.4 Apotex Revenue in Pediatric HIV Infection Treatment Business (2016-2021)
11.5.5 Apotex Recent Development
11.6 Camber Pharmaceuticals
11.6.1 Camber Pharmaceuticals Company Details
11.6.2 Camber Pharmaceuticals Business Overview
11.6.3 Camber Pharmaceuticals Pediatric HIV Infection Treatment Introduction
11.6.4 Camber Pharmaceuticals Revenue in Pediatric HIV Infection Treatment Business (2016-2021)
11.6.5 Camber Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pediatric HIV Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Not Symptomatic
Table 3. Key Players of Mildly Symptomatic
Table 4. Key Players of Moderately Symptomatic
Table 5. Key Players of Severely Symptomatic
Table 6. Global Pediatric HIV Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pediatric HIV Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pediatric HIV Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pediatric HIV Infection Treatment Market Share by Regions (2016-2021)
Table 10. Global Pediatric HIV Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pediatric HIV Infection Treatment Market Share by Regions (2022-2027)
Table 12. Pediatric HIV Infection Treatment Market Trends
Table 13. Pediatric HIV Infection Treatment Market Drivers
Table 14. Pediatric HIV Infection Treatment Market Challenges
Table 15. Pediatric HIV Infection Treatment Market Restraints
Table 16. Global Pediatric HIV Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pediatric HIV Infection Treatment Market Share by Players (2016-2021)
Table 18. Global Top Pediatric HIV Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric HIV Infection Treatment as of 2020)
Table 19. Ranking of Global Top Pediatric HIV Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pediatric HIV Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pediatric HIV Infection Treatment Product Solution and Service
Table 23. Date of Enter into Pediatric HIV Infection Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric HIV Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pediatric HIV Infection Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Pediatric HIV Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pediatric HIV Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pediatric HIV Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pediatric HIV Infection Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Pediatric HIV Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pediatric HIV Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pediatric HIV Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pediatric HIV Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pediatric HIV Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pediatric HIV Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pediatric HIV Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pediatric HIV Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pediatric HIV Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pediatric HIV Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pediatric HIV Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pediatric HIV Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pediatric HIV Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pediatric HIV Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pediatric HIV Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pediatric HIV Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pediatric HIV Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pediatric HIV Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pediatric HIV Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pediatric HIV Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pediatric HIV Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pediatric HIV Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Pediatric HIV Infection Treatment Product
Table 66. GSK Revenue in Pediatric HIV Infection Treatment Business (2016-2021) & (US$ Million)
Table 67. GSK Recent Development
Table 68. F.Hoffmann-La Roche Company Details
Table 69. F.Hoffmann-La Roche Business Overview
Table 70. F.Hoffmann-La Roche Pediatric HIV Infection Treatment Product
Table 71. F.Hoffmann-La Roche Revenue in Pediatric HIV Infection Treatment Business (2016-2021) & (US$ Million)
Table 72. F.Hoffmann-La Roche Recent Development
Table 73. Johnson & Johnson Services Company Details
Table 74. Johnson & Johnson Services Business Overview
Table 75. Johnson & Johnson Services Pediatric HIV Infection Treatment Product
Table 76. Johnson & Johnson Services Revenue in Pediatric HIV Infection Treatment Business (2016-2021) & (US$ Million)
Table 77. Johnson & Johnson Services Recent Development
Table 78. ViiV Healthcare Company Details
Table 79. ViiV Healthcare Business Overview
Table 80. ViiV Healthcare Pediatric HIV Infection Treatment Product
Table 81. ViiV Healthcare Revenue in Pediatric HIV Infection Treatment Business (2016-2021) & (US$ Million)
Table 82. ViiV Healthcare Recent Development
Table 83. Apotex Company Details
Table 84. Apotex Business Overview
Table 85. Apotex Pediatric HIV Infection Treatment Product
Table 86. Apotex Revenue in Pediatric HIV Infection Treatment Business (2016-2021) & (US$ Million)
Table 87. Apotex Recent Development
Table 88. Camber Pharmaceuticals Company Details
Table 89. Camber Pharmaceuticals Business Overview
Table 90. Camber Pharmaceuticals Pediatric HIV Infection Treatment Product
Table 91. Camber Pharmaceuticals Revenue in Pediatric HIV Infection Treatment Business (2016-2021) & (US$ Million)
Table 92. Camber Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric HIV Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Not Symptomatic Features
Figure 3. Mildly Symptomatic Features
Figure 4. Moderately Symptomatic Features
Figure 5. Severely Symptomatic Features
Figure 6. Global Pediatric HIV Infection Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drugstore Case Studies
Figure 11. Others Case Studies
Figure 12. Pediatric HIV Infection Treatment Report Years Considered
Figure 13. Global Pediatric HIV Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Pediatric HIV Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pediatric HIV Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Pediatric HIV Infection Treatment Market Share by Regions (2022-2027)
Figure 17. Global Pediatric HIV Infection Treatment Market Share by Players in 2020
Figure 18. Global Top Pediatric HIV Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric HIV Infection Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Pediatric HIV Infection Treatment Revenue in 2020
Figure 20. Global Pediatric HIV Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Pediatric HIV Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Pediatric HIV Infection Treatment Market Share by Type (2016-2027)
Figure 24. North America Pediatric HIV Infection Treatment Market Share by Application (2016-2027)
Figure 25. North America Pediatric HIV Infection Treatment Market Share by Country (2016-2027)
Figure 26. United States Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pediatric HIV Infection Treatment Market Share by Type (2016-2027)
Figure 30. Europe Pediatric HIV Infection Treatment Market Share by Application (2016-2027)
Figure 31. Europe Pediatric HIV Infection Treatment Market Share by Country (2016-2027)
Figure 32. Germany Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pediatric HIV Infection Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Pediatric HIV Infection Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Pediatric HIV Infection Treatment Market Share by Region (2016-2027)
Figure 42. China Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pediatric HIV Infection Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Pediatric HIV Infection Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Pediatric HIV Infection Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pediatric HIV Infection Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Pediatric HIV Infection Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Pediatric HIV Infection Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Pediatric HIV Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. GSK Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2016-2021)
Figure 62. F.Hoffmann-La Roche Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Services Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2016-2021)
Figure 64. ViiV Healthcare Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2016-2021)
Figure 65. Apotex Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2016-2021)
Figure 66. Camber Pharmaceuticals Revenue Growth Rate in Pediatric HIV Infection Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Clostridium Botulinum Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4028 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ボツリヌス菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素療法、細心気道管理、人工呼吸補助）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年）

Global Sporothrix Schenckii Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4897 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、スポロトリクスシェンキー感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イトラコナゾール薬、アムホテリシンB薬、ヨウ化カリウム飽和溶液（SSKI）、手術、その他）、用途別市場規模（病院、専門...

世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6058 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎...

世界の皮膚・軟部組織感染症治療市場規模・現状・予測（2021年-2027年）

Global Skin and Soft Tissue Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4865 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚・軟部組織感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗真菌剤、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、...

世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4533 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...

世界の小児硝子体手術市場規模・現状・予測（2021年-2027年）

Global Pediatric Vitrectomy Market Size, Status and Forecast 2021-2027
QFJ1-4677 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、小児硝子体手術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（毛様体扁平部硝子体切除術、前部硝子体切除術）、用途別市場規模（病院、眼科クリニック、外来手術センター、その他）、主要地域別市場規模（北米、...

世界の寄生虫感染症検査市場規模・現状・予測（2021年-2027年）

Global Parasitic Infection Testing Market Size, Status and Forecast 2021-2027
QFJ1-4656 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、寄生虫感染症検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（顕微鏡検査、血清学的検査、分子ベースアッセイ、プロテオミクス検査）、用途別市場規模（病院、クリニック、診断研究所、その他）、主要地域別市...

世界のポイントオブケア感染管理市場規模・現状・予測（2021年-2027年）

Global Point Of Care Infection Control Market Size, Status and Forecast 2021-2027
QFJ1-4723 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ポイントオブケア感染管理の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（皮膚殺菌、環境消毒、その他）、用途別市場規模（病院、クリニック、在宅医療施設、外来手術センター）、主要地域別市場規模（北米、アメ...

世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年）

Global Respiratory Infection Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5333 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、呼吸器感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（微生物、PCR、NGS、イムノアッセイ）、用途別市場規模（病院研究室、外来研究室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のジカウイルス感染治療薬市場規模・現状・予測（2021年-2027年）

Global Zika Virus Infection Drug Market Size, Status and Forecast 2021-2027
QFJ1-5048 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ジカウイルス感染治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射剤）、用途別市場規模（病院、在宅医療、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年） Clostridium botulinum infections are caused by clostridium botulinum, a gram-positive, rod-shaped bacterium which produces an extremely lethal substance that is botulism neurotoxin. Market Analysis and Insights: Global Clostridium Botulinum Infection Treatment Market The global Clostridium Botulinum…
世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年） Skin-related issues are one of the frequently occurring issues worldwide. One such issue is Sporotrichosis. Sporotrichosis is caused by a dimorphic fungus, called Sporothrix Schenckii, and is commonly called gardeners' disease due to number of people affected when carrying out cultivation in farms a…
世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
世界の皮膚・軟部組織感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Skin and Soft Tissue Infection Treatment Market The global Skin and Soft Tissue Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年） Multidrug-resistant bacteria (MDROS), also known as multidrug-resistant microorganisms, are the result of bacterial variation and excessive use of antimicrobial agents. Market Analysis and Insights: Global Multiple Drug Resistance Bacterial Infection Treatment Market The global Multiple Drug Resista…